封面
市场调查报告书
商品编码
1386337

全球心率管理设备市场:趋势、预测与竞争分析(~2030 年)

Cardiac Rhythm Management Devices Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

心率管理设备的趋势和预测

预计2030年,全球心率管理设备市场规模将达到约193亿美元,2024年至2030年年复合成长率为4.5%。该市场的主要驱动因素是心血管疾病盛行率的上升、人们对心率管理设备益处的认识不断提高,以及技术的不断进步,导致更有效、侵入性更小的新型创新设备正在开发中。全球心率管理设备市场的未来充满希望,医院/诊所和门诊手术中心市场充满机会。

心率管理设备市场洞察

Lucintel 预测,由于院外心臟麻痹率不断上升,心臟去颤器在预测期内仍将是最大的细分市场。

在这个市场中,医院和诊所预计仍将是最大的部分。

由于老年人口的快速增长和先进的医疗保健系统的存在,北美仍然是最大的地区。

市场规模/估算:心率管理设备的金额规模估算(10 亿美元)

趋势和预测分析:各细分市场和地区的市场趋势(2018-2023)和预测(2024-2030)

细分市场分析:按产品类型、最终用途和金额区域估算心率管理设备的市场规模(十亿美元)

区域分析:北美、欧洲、亚太地区和世界其他地区心率

成长机会:心率管理设备市场按产品类型、最终用途和地区分類的成长机会分析

策略分析:包括心率管理设备市场併购、新产品开发、竞争形势等

基于波特五力模型的产业竞争实力分析

本报告回答了 11 个关键问题:

  • Q.1. 细分市场中最有前途和高成长的机会是什么?
  • Q.2.哪个细分市场将以更快的速度成长?为什么?
  • Q.3.您认为哪些地区未来会出现更快的成长?为什么?
  • Q.4. 影响市场动态的主要因素有哪些?市场的主要挑战和商业风险是什么?
  • Q.5. 这个市场的商业风险和竞争威胁是什么?
  • Q.6.这个市场有哪些新趋势?为什么?
  • Q.7.市场客户需求有何改变?
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位?
  • Q.9.这个市场的主要企业有哪些?主要企业采取哪些策略配合措施来发展业务?
  • Q.10. 该市场上的竞争产品有哪些?由于材料或产品替代而导致市场占有率下降的威胁有多大?
  • Q.11.过去年度发生了哪些併购事件,对产业产生了哪些影响?

目录

第1章执行摘要

第2章全球心率管理设备市场:市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势与预测分析

  • 宏观经济趋势(2018-2023)与预测(2024-2030)
  • 全球心率管理设备市场趋势(2018-2023)与预测(2024-2030)
  • 全球心率管理设备市场:依产品类型
    • 心臟起搏器
    • 心臟去颤器
    • 心臟再同步治疗装置
  • 全球心率管理设备市场:依最终用途分类
    • 医院/诊所
    • 门诊手术中心
    • 其他的

第4章市场趋势与预测分析:按地区(2018-2030)

  • 全球心率管理设备市场:按地区
  • 北美心率管理设备市场
  • 欧洲心率管理设备市场
  • 亚太心率管理设备市场
  • 其他地区心率管理设备市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球心率管理设备市场成长机会
    • 全球心率管理设备市场成长机会(依最终用途)
    • 按地区分類的全球心率管理设备市场成长机会
  • 全球心率管理设备市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球心率管理设备市场的产能
    • 全球心率管理设备市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • Physio-Control
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Schiller
  • Koninklijke Philips
  • BIOTRONIK
  • Progetti
  • Zoll Medical Corporation
  • LivaNova
简介目录

Cardiac Rhythm Management Devices Trends and Forecast

The future of the global cardiac rhythm management devices market looks promising with opportunities in the hospital & clinic and ambulatory surgery center markets. The global cardiac rhythm management devices market is expected to reach an estimated $19.3 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are rising prevalence of cardiovascular diseases, growing awareness towards the benefits of cardiac rhythm management devices, and on-going technological advancements are resulting in development of new and innovative devices that are more effective and less invasive.

A more than 150-page report is developed to help in your business decisions.

Cardiac Rhythm Management Devices by Segment

The study includes a forecast for the global cardiac rhythm management devices by product type, end use, and region.

Cardiac Rhythm Management Devices Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Cardiac Pacemakers
  • Defibrillators
  • Cardiac Resynchronization Therapy Devices

Cardiac Rhythm Management Devices Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Ambulatory Surgery Centers
  • Others

Cardiac Rhythm Management Devices Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cardiac Rhythm Management Devices Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cardiac rhythm management devices companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cardiac rhythm management devices companies profiled in this report include-

  • Physio-Control
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Schiller
  • Koninklijke Philips
  • Biotronik
  • Progetti
  • Zoll Medical Corporation
  • Livanova

Cardiac Rhythm Management Devices Market Insights

Lucintel forecasts that defibrillators will remain the largest segment over the forecast period due to the rising prevalence of out-of-hospital cardiac arrests.

Within this market, hospitals and clinics is expected to remain the largest segment.

North America will remain the largest region due to surge in elderly population and presence of advanced healthcare system in the region.

Features of the Global Cardiac Rhythm Management Devices Market

Market Size Estimates: Cardiac rhythm management devices market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cardiac rhythm management devices market size by product type, end use, and region in terms of value ($B).

Regional Analysis: Cardiac rhythm management devices market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, end uses, and regions for the cardiac rhythm management devices market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cardiac rhythm management devices market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the cardiac rhythm management devices market size?

Answer: The global cardiac rhythm management devices market is expected to reach an estimated $19.3 billion by 2030.

Q.2 What is the growth forecast for cardiac rhythm management devices market?

Answer: The global cardiac rhythm management devices market is expected to grow with a CAGR of 4.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the cardiac rhythm management devices market?

Answer: The major drivers for this market are rising prevalence of cardiovascular diseases, growing awareness towards the benefits of cardiac rhythm management devices, and on-going technological advancements are resulting in development of new and innovative devices that are more effective and less invasive.

Q4. What are the major segments for cardiac rhythm management devices market?

Answer: The future of the cardiac rhythm management devices market looks promising with opportunities in the hospital & clinic and ambulatory surgery center markets.

Q5. Who are the key cardiac rhythm management devices market companies?

Answer: Some of the key cardiac rhythm management devices companies are as follows:

  • Physio-Control
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Schiller
  • Koninklijke Philips
  • Biotronik
  • Progetti
  • Zoll Medical Corporation
  • Livanova

Q6. Which cardiac rhythm management devices market segment will be the largest in future?

Answer: Lucintel forecasts that defibrillators will remain the largest segment over the forecast period due to the rising prevalence of out-of-hospital cardiac arrests.

Q7. In cardiac rhythm management devices market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to surge in elderly population and presence of advanced healthcare system in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cardiac rhythm management devices market by product type (cardiac pacemakers, defibrillators, and cardiac resynchronization therapy devices), end use (hospitals & clinics, ambulatory surgery centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cardiac Rhythm Management Devices Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cardiac Rhythm Management Devices Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cardiac Rhythm Management Devices Market by Product Type
    • 3.3.1: Cardiac Pacemakers
    • 3.3.2: Defibrillators
    • 3.3.3: Cardiac Resynchronization Therapy Devices
  • 3.4: Global Cardiac Rhythm Management Devices Market by End Use
    • 3.4.1: Hospitals & Clinics
    • 3.4.2: Ambulatory Surgery Centers
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cardiac Rhythm Management Devices Market by Region
  • 4.2: North American Cardiac Rhythm Management Devices Market
    • 4.2.2: North American Cardiac Rhythm Management Devices Market by End Use: Hospitals & Clinics, Ambulatory Surgery Centers, and Others
  • 4.3: European Cardiac Rhythm Management Devices Market
    • 4.3.1: European Cardiac Rhythm Management Devices Market by Product Type: Cardiac Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices
    • 4.3.2: European Cardiac Rhythm Management Devices Market by End Use: Hospitals & Clinics, Ambulatory Surgery Centers, and Others
  • 4.4: APAC Cardiac Rhythm Management Devices Market
    • 4.4.1: APAC Cardiac Rhythm Management Devices Market by Product Type: Cardiac Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices
    • 4.4.2: APAC Cardiac Rhythm Management Devices Market by End Use: Hospitals & Clinics, Ambulatory Surgery Centers, and Others
  • 4.5: ROW Cardiac Rhythm Management Devices Market
    • 4.5.1: ROW Cardiac Rhythm Management Devices Market by Product Type: Cardiac Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices
    • 4.5.2: ROW Cardiac Rhythm Management Devices Market by End Use: Hospitals & Clinics, Ambulatory Surgery Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cardiac Rhythm Management Devices Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Cardiac Rhythm Management Devices Market by End Use
    • 6.1.3: Growth Opportunities for the Global Cardiac Rhythm Management Devices Market by Region
  • 6.2: Emerging Trends in the Global Cardiac Rhythm Management Devices Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cardiac Rhythm Management Devices Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cardiac Rhythm Management Devices Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Physio-Control
  • 7.2: Medtronic
  • 7.3: Abbott
  • 7.4: Boston Scientific Corporation
  • 7.5: Schiller
  • 7.6: Koninklijke Philips
  • 7.7: BIOTRONIK
  • 7.8: Progetti
  • 7.9: Zoll Medical Corporation
  • 7.10: LivaNova